These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2627635)

  • 1. The fate of G3pT1 bladder cancer.
    Jenkins BJ; Nauth-Misir RR; Martin JE; Fowler CG; Hope-Stone HF; Blandy JP
    Br J Urol; 1989 Dec; 64(6):608-10. PubMed ID: 2627635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours.
    Vicente J; Laguna MP; Duarte D; Algaba F; Chéchile G
    Br J Urol; 1991 Oct; 68(4):380-2. PubMed ID: 1933158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA analysis in predicting survival of irradiated patients with transitional cell carcinoma of bladder.
    Wijkström H; Nilsson B; Tribukait B
    Br J Urol; 1992 Jan; 69(1):49-55. PubMed ID: 1737253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological analysis of high-grade superficial bladder tumour.
    Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Ishii N; Kawamura S; Nakada T; Suzuki K
    Int Urol Nephrol; 1991; 23(3):237-43. PubMed ID: 1889970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival.
    Parker WP; Ho PL; Melquist JJ; Scott K; Holzbeierlein JM; Lopez-Corona E; Kamat AM; Lee EK
    J Urol; 2015 May; 193(5):1494-9. PubMed ID: 25451834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy?
    Quilty PM; Hargreave TB; Smith G; Duncan W
    Br J Urol; 1987 Mar; 59(3):242-7. PubMed ID: 3567486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of factors influencing the outcome of radiotherapy for bladder cancer.
    Davidson SE; Symonds RP; Snee MP; Upadhyay S; Habeshaw T; Robertson AG
    Br J Urol; 1990 Sep; 66(3):288-93. PubMed ID: 2119844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.
    Gospodarowicz MK; Hawkins NV; Rawlings GA; Connolly JG; Jewett MA; Thomas GM; Herman JG; Garrett PG; Chua T; Duncan W
    J Urol; 1989 Dec; 142(6):1448-53; discussion 1453-4. PubMed ID: 2585617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
    Serretta V; Lo Greco G; Pavone C; Pavone-Macaluso M
    J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the outcome of radical radiotherapy for invasive bladder cancer.
    Vale JA; A'Hern RP; Liu K; Hendry WF; Whitfield HN; Plowman PN; Sowter C; Slavin G
    Eur Urol; 1993; 24(1):48-51. PubMed ID: 8365439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
    Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
    Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in 243 transitional carcinomas of the bladder (I): clinical and macroscopic parameters of the tumor].
    Portillo Martín JA; Val Bernal F; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Garijo Ayenza F; Buelta Carrillo L; Fernández Gómez JM; Concepción Masip T
    Arch Esp Urol; 1991 Mar; 44(2):151-8. PubMed ID: 1867490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of superficial (T1) tumours of the bladder by radical radiotherapy.
    Quilty PM; Duncan W
    Br J Urol; 1986 Apr; 58(2):147-52. PubMed ID: 3083903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors influencing treatment results of definitive radiotherapy following transurethral surgery for muscle-invasive bladder cancer].
    Abe T; Kanehira C
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Sep; 59(11):516-20. PubMed ID: 10536447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
    J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and cystectomy for T3 bladder carcinoma.
    Hall RR; Heath AB
    Br J Urol; 1981 Dec; 53(6):598-601. PubMed ID: 7317748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.